1-ethyl-2-benzimidazolinone has been researched along with tram 39 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinton, JM; Langton, PD | 1 |
| Burnham, MP; Johnson, IT; Weston, AH | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and tram 39
| Article | Year |
|---|---|
Inhibition of EDHF by two new combinations of K+-channel inhibitors in rat isolated mesenteric arteries.
Topics: 4-Aminopyridine; Acetonitriles; Animals; Apamin; Benzimidazoles; Biological Factors; Charybdotoxin; Dose-Response Relationship, Drug; Male; Mesenteric Arteries; Potassium Channels, Calcium-Activated; Potassium Channels, Voltage-Gated; Rats; Rats, Wistar; Scorpion Venoms; Scorpions; Trityl Compounds | 2003 |
Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in Type II diabetic ZDF rats.
Topics: Acetonitriles; Animals; Benzimidazoles; Biological Factors; Diabetes Mellitus, Type 2; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; Small-Conductance Calcium-Activated Potassium Channels; Trityl Compounds | 2006 |